Risk of Subsequent Revision after Primary and Revision Total Joint Arthroplasty

被引:225
作者
Ong, Kevin L. [1 ]
Lau, Edmund [2 ]
Suggs, Jeremy [1 ]
Kurtz, Steven M. [1 ]
Manley, Michael T. [3 ]
机构
[1] Exponent Inc, Philadelphia, PA 19104 USA
[2] Exponent Inc, Menlo Pk, CA USA
[3] Homer Stryker Ctr Orthopaed Educ & Res, Mahwah, NJ USA
关键词
TOTAL HIP-REPLACEMENT; SURGEON PROCEDURE VOLUME; KNEE ARTHROPLASTY; UNITED-STATES; OUTCOMES; INDEX; ASSOCIATION; INFECTION; IMPACT;
D O I
10.1007/s11999-010-1399-0
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background Revision is technically more demanding than primary total joint arthroplasty (TJA) and requires more extensive use of resources. Understanding the relative risk of rerevision and risk factors can help identify patients at high risk who may require closer postsurgical care. Objectives/purposes We therefore evaluated the risk of subsequent revision after primary and revision TJA in the elderly (65 years or older) patient population and identified corresponding patient risk factors. Patients and Methods Using the 5% Medicare claims data set (1997-2006), we identified a total of 35,746 patients undergoing primary THA and 72,913 undergoing primary TKA; of these, 1205 who had THAs and 1599 who had TKAs underwent initial revision surgery. The rerevision rate after primary and revision TJAs was analyzed by the Kaplan-Meier method. The relative risk of revision surgery for primary and revision TJAs was compared using hazard ratio analysis. Results The 5-year survival probabilities were 95.9%, 97.2%, 81.0%, and 87.4% for primary THA and TKA and revision THA and TKA, respectively. Patients with revision arthroplasty were five to six times more likely to undergo rerevision (adjusted relative risk, 4.89 for THA; 5.71 for TKA) compared with patients with primary arthroplasty. Age and comorbidities were associated with initial revision after primary THA and TKA. Conclusions Patients should undergo stringent preoperative screening for preexisting health conditions and careful patient management and followup postoperatively so as to minimize the risk of an initial revision, which otherwise could lead to a significantly greater likelihood of subsequent rerevisions. Level of Evidence Level II, prognostic study. See Guideline for Authors for a complete description of levels of evidence.
引用
收藏
页码:3070 / 3076
页数:7
相关论文
共 33 条
[1]  
Australian Orthopaedic Association National Joint Registry, HIP KNEE ARTHR ANN R
[2]   High body mass index is associated with increased risk of implant dislocation following primary total hip replacement - 2,106 patients followed for up to 8 years [J].
Azodi, Omid Sadr ;
Adami, Johanna ;
Lindstroem, David ;
Eriksson, Karl O. ;
Wladis, Andreas ;
Bellocco, Rino .
ACTA ORTHOPAEDICA, 2008, 79 (01) :141-147
[3]   The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization [J].
Bozic, KJ ;
Ries, MD .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2005, 87A (08) :1746-1751
[4]   Hospital resource utilization for primary and revision total hip arthroplasty [J].
Bozic, KJ ;
Katz, P ;
Cisternas, M ;
Ono, L ;
Ries, MD ;
Showstack, J .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2005, 87A (03) :570-576
[5]  
Bozic KJ., CMS CHANGES ICD 9 DR
[6]   Cost effectiveness of revision total knee arthroplasty [J].
Burns, Alexander W. R. ;
Bourne, Robert B. ;
Chesworth, Bert M. ;
MacDonald, Steven J. ;
Rorabeck, Cecil H. .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2006, (446) :29-33
[7]   Revision total knee arthroplasty [J].
Dennis, Douglas A. ;
Berry, Daniel J. ;
Engh, Gerard ;
Fehring, Thomas ;
MacDonald, Steven J. ;
Rosenberg, Aaron Glen ;
Scuderi, Giles .
JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS, 2008, 16 (08) :442-454
[8]   ADAPTING A CLINICAL COMORBIDITY INDEX FOR USE WITH ICD-9-CM ADMINISTRATIVE DATABASES [J].
DEYO, RA ;
CHERKIN, DC ;
CIOL, MA .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (06) :613-619
[9]  
Fehring Thomas K, 2008, Instr Course Lect, V57, P341
[10]  
Jaffer AK, 2005, MAYO CLIN PROC, V80, P732